4th Circ. Undoes $1.25M Verdict In Pradaxa Suit
By Emily Field · January 6, 2021, 6:43 PM EST
The Fourth Circuit on Wednesday reversed a $1.25 million verdict against Boehringer Ingelheim in a suit over the bleeding risks of its blood thinner Pradaxa, finding that fraud claims brought by...
To view the full article, register now.